Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stancenews2024-12-04T21:23:56+00:00December 4th, 2024|The New York Times|
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
A Kennedy no le gusta Ozempic, esto es lo que podría hacer al respectonews2024-11-26T08:00:57+00:00November 26th, 2024|The New York Times|
Dr Martin Makary Chosen to Head the FDAnews2024-11-23T02:15:50+00:00November 23rd, 2024|The New York Times|
Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Knownews2024-11-22T21:06:45+00:00November 22nd, 2024|The New York Times|
F.D.A.: Some Clonazepam Recalled Over Incorrect Doses on Labelsnews2024-11-22T17:26:32+00:00November 22nd, 2024|The New York Times|
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claimsnews2024-11-16T03:21:15+00:00November 16th, 2024|The New York Times|
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovationnews2024-11-09T01:04:06+00:00November 9th, 2024|The New York Times|
F.D.A. Wants to Pull Ineffective Decongestant From Storesnews2024-11-07T20:31:25+00:00November 7th, 2024|The New York Times|
